These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31999471)
41. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619 [TBL] [Abstract][Full Text] [Related]
42. Ataxia-telangiectasia mutated activation mediates tumor necrosis factor-alpha induced MMP-13 up-regulation and metastasis in lung cancer cells. Yan HQ; Zhang D; Shi YY; You X; Shi L; Li Q; Gao FG Oncotarget; 2016 Sep; 7(38):62070-62083. PubMed ID: 27556690 [TBL] [Abstract][Full Text] [Related]
43. TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway. Xiong Y; Feng Y; Zhao J; Lei J; Qiao T; Zhou Y; Lu Q; Jiang T; Jia L; Han Y Cell Death Dis; 2021 Apr; 12(4):352. PubMed ID: 33824285 [TBL] [Abstract][Full Text] [Related]
44. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1. Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210 [TBL] [Abstract][Full Text] [Related]
45. Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway. An Y; Zhang Q; Li X; Wang Z; Li Y; Tang X Biomed Pharmacother; 2018 Dec; 108():1845-1855. PubMed ID: 30372890 [TBL] [Abstract][Full Text] [Related]
46. MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition. Zhu C; Deng X; Wu J; Zhang J; Yang H; Fu S; Zhang Y; Han Y; Zou Y; Chen Z; Lin S Tumour Biol; 2016 Aug; 37(8):11289-97. PubMed ID: 26951513 [TBL] [Abstract][Full Text] [Related]
47. Knockdown of LINC01614 inhibits lung adenocarcinoma cell progression by up-regulating miR-217 and down-regulating FOXP1. Liu AN; Qu HJ; Yu CY; Sun P J Cell Mol Med; 2018 Sep; 22(9):4034-4044. PubMed ID: 29934982 [TBL] [Abstract][Full Text] [Related]
48. The effect of miR-496 on eIF3h in lung invasive adenocarcinoma. Ji-Chun Acta Biochim Pol; 2021 May; 68(4):627-632. PubMed ID: 34038061 [TBL] [Abstract][Full Text] [Related]
49. Cluster of differentiation 44 promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin. Ma J; Klemm J; Gerardo-Ramírez M; Frappart L; Castven D; Becker D; Zoch A; Parent R; Bartosch B; Minnich K; Giovannini M; Danckwardt S; Hartmann N; Morrison H; Herrlich P; Marquardt JU; Hartmann M Int J Cancer; 2020 Nov; 147(9):2564-2577. PubMed ID: 32525563 [TBL] [Abstract][Full Text] [Related]
50. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951 [TBL] [Abstract][Full Text] [Related]
51. Inflammation-mediated SOD-2 upregulation contributes to epithelial-mesenchymal transition and migration of tumor cells in aflatoxin G Yi L; Shen H; Zhao M; Shao P; Liu C; Cui J; Wang J; Wang C; Guo N; Kang L; Lv P; Xing L; Zhang X Sci Rep; 2017 Aug; 7(1):7953. PubMed ID: 28801561 [TBL] [Abstract][Full Text] [Related]
52. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2. Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902 [TBL] [Abstract][Full Text] [Related]
53. miR-590 accelerates lung adenocarcinoma migration and invasion through directly suppressing functional target OLFM4. Liu Y; Wang F; Xu P Biomed Pharmacother; 2017 Feb; 86():466-474. PubMed ID: 28012926 [TBL] [Abstract][Full Text] [Related]
54. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells. Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317 [TBL] [Abstract][Full Text] [Related]
55. Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth. Zhang YX; Yan YF; Liu YM; Li YJ; Zhang HH; Pang M; Hu JX; Zhao W; Xie N; Zhou L; Wang PY; Xie SY Cell Death Dis; 2016 Dec; 7(12):e2528. PubMed ID: 28005074 [TBL] [Abstract][Full Text] [Related]
56. Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients. González-Vallinas M; Rodríguez-Paredes M; Albrecht M; Sticht C; Stichel D; Gutekunst J; Pitea A; Sass S; Sánchez-Rivera FJ; Lorenzo-Bermejo J; Schmitt J; De La Torre C; Warth A; Theis FJ; Müller NS; Gretz N; Muley T; Meister M; Tschaharganeh DF; Schirmacher P; Matthäus F; Breuhahn K Mol Cancer Res; 2018 Mar; 16(3):390-402. PubMed ID: 29330288 [TBL] [Abstract][Full Text] [Related]
57. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Liu B; Wu X; Liu B; Wang C; Liu Y; Zhou Q; Xu K Biochim Biophys Acta; 2012 Nov; 1822(11):1692-704. PubMed ID: 22885155 [TBL] [Abstract][Full Text] [Related]
59. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion. Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556 [TBL] [Abstract][Full Text] [Related]
60. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma. Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]